NH4-6
NH4-6 is a SIRT2 inhibitor with an IC50 of 0.032 μM against SIRT2 and an IC50 of 3 μM against SIRT1. NH4-6 inhibits the deacetylase activity of SIRT1. As a cytotoxic agent, NH4-6 reduces cancer cell viability, suppresses anchorage-independent growth of cancer cells, induces acetylation of α-tubulin, and promotes acetylation of p53. NH4-6 can be used in the research of breast cancer.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 2375182-58-2
- Formule: C33H59IN4O3S
- Masse moléculaire:718.82
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
IC50 & Target
[1]|
SIRT2 0.032 μM (IC50) |
SIRT1 3 μM (IC50) |
In Vitro
NH4-6 potently and selectively inhibits purified SIRT2 deacetylase activity with an IC50 of 0.032 μM, shows weaker activity against SIRT1 and SIRT6, and does not inhibit SIRT3 at 83 μM[1].
NH4-6 (25-50 μM; 6 h for permeability) exhibits weaker cytotoxicity than TM at 25 μM but stronger cytotoxicity at 50 μM in MCF7 and MDA-MB-231 breast cancer cells, correlating with its concentration-dependent cellular uptake enabled by superior aqueous solubility[1].
NH4-6 (12 μM; 10 days) shows stronger inhibition of anchorage-independent growth than TM at 12 μM in MCF7 breast cancer cells[1].
NH4-6 (25-100 μM; 6 h) increases α-tubulin acetylation (a marker of SIRT2 inhibition) in MCF7 breast cancer cells at 50 μM and 100 μM, but not at 25 μM, consistent with its concentration-dependent cellular uptake[1].
NH4-6 (10-100 μM) inhibits SIRT1 activity (measured via p53 acetylation) in MCF7 breast cancer cells only at a concentration of 100 μM, likely due to its improved solubility enabling sufficient cellular accumulation[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:MCF7, MDA-MB-231 breast cancer cells
-
Concentration:25 μM, 50 μM
-
Incubation Time:6 h
-
Result:Showed slightly weaker cytotoxicity than TM in both MCF7 and MDA-MB-231 cells at lower concentrations.
Showed stronger cytotoxicity than TM in both cell lines at 50 μM.
Reached intracellular levels of 0.19 μg/million cells after 25 μM treatment and 0.86 μg/million cells after 50 μM treatment, compared to saturated levels of TM (~0.29-0.30 μg/million cells) at both concentrations.
-
Cell Line:MCF7 breast cancer cells
-
Concentration:25 μM; 50 μM; 100 μM
-
Incubation Time:6 h
-
Result:Did not increase α-tubulin acetylation levels at 25 μM.
Increased α-tubulin acetylation levels to levels comparable to TM-treated samples at 50 μM and 100 μM.
Chemical Information
-
CAS No. 2375182-58-2
-
Masse moléculaire 718.82
-
Formule C33H59IN4O3S
-
SMILES
O=C(OCC1=CC=CC=C1)N[C@@H](CCCCNC(CCCCCCCCCCCCC)=S)C(NCC[N+](C)(C)C)=O.[I-]
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocole
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Mammalian live/dead viability and cytotoxicity staining
Live/dead viability and cytotoxicity staining assays are based on the simultaneous detection of intracellular esterase activity in metabolically active (viable) cells and membrane integrity loss in non-viable cells. In commonly used dual-staining approaches, membrane-permeant fluorogenic substrates are converted by intracellular esterases into fluorescent products in live cells, while impermeant DNA-binding dyes selectively enter cells with compromised plasma membranes and label nucleic acids in dead or dying cells, enabling discrimination between viable and non-viable populations by fluorescence microscopy or flow cytometry.
-
CCK-8/WST-8 Cell Proliferation Assay
The CCK-8/WST-8 assay is based on the reduction of the water-soluble tetrazolium salt WST-8 to a water-soluble formazan product by cellular dehydrogenases in metabolically active cells, where the generated formazan amount is proportional to the number of living cells and is quantified by measuring absorbance in the visible range, providing a colorimetric readout for cell viability and proliferation assessment. This class of tetrazolium-based assays improves upon earlier MTT-based systems by producing a water-soluble formazan, eliminating the need for organic solubilization steps and enabling direct spectrophotometric measurement in culture medium.
-
Soft Agar Colony Formation Assay
Soft agar colony formation assay measures anchorage-independent growth, in which transformed or tumorigenic cells proliferate as colonies in a semisolid agar matrix while many non-transformed adherent cells fail to proliferate without attachment; classic studies showed that growth in semisolid medium correlates with tumorigenicity in nude mice, and later protocol papers describe the method as a stringent in vitro assay for malignant transformation. The readout is the number, size, morphology, or signal intensity of colonies formed within agar after incubation; published formats include manual colony counting after staining, 96-well or 384-well quantitative formats, DNA-binding dye detection, MTT/tetrazolium-based detection, digital image analysis, and PCR-based marker detection from soft agar cultures.
-
MTT Cell Proliferation Assay
The MTT assay is a colorimetric endpoint assay for estimating viable cell number, cell growth, cytotoxicity, or cell activation in cultured mammalian cells. Living cells reduce the yellow tetrazolium salt MTT into purple/blue formazan, while dead cells do not generate the same signal; the resulting color can be quantified with a multiwell spectrophotometer. MTT reduction is commonly interpreted as a readout of metabolic activity that often correlates with viable cell number, but it should not be treated as a direct cell-counting method unless the assay is optimized for the cell type and experimental condition. Studies show that MTT reduction can involve mitochondrial and non-mitochondrial reducing systems, and formazan may accumulate in intracellular lipid droplets rather than simply marking mitochondria.
-
Breast Cancer Modeling
Breast cancer is a heterogeneous cancer, and it has been distinguished into four subtypes: luminal A, luminal B, HER2-positive and basal-like. Molecular mutations, epigenetic alterations, hormone exposure and immune microenvironment are related to the progression of breast cancer.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)